Income Statement

NATIONAL HEALTH INVESTORS INC

NHI
Annual
Performance Overview Click any row in the table to add it to this chart
in millions USD
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Dec 31, 2020 2020 FY Dec 31, 2019 2019 FY Dec 31, 2018 2018 FY Dec 31, 2017 2017 FY Dec 31, 2016 2016 FY Dec 31, 2015 2015 FY Dec 31, 2014 2014 FY Dec 31, 2013 2013 FY Dec 31, 2011 2011 FY Dec 31, 2010 2010 FY
Revenue
375.63 335.18 319.84 278.19 298.72 332.81 318.08 294.61 278.66 248.50 228.99 177.51 117.83 82.70 78.40
Cost of Revenue
- - - - - - - - - - - - - - -
Gross Profit
375.63 335.18 319.84 278.19 298.72 332.81 318.08 294.61 278.66 248.50 228.99 177.51 117.83 82.70 78.40
Operating Expenses
238.96 211.88 200.88 241.86 216.14 161.77 156.81 139.54 127.17 129.73 102.27 74.39 41.96 20.84 19.90
Research & Development
- - - - - - - - - - - - - - -
Selling, General & Administrative
26.87 20.74 19.31 22.77 18.43 13.30 13.40 12.55 12.22 9.77 10.52 9.11 9.25 7.47 7.70
Other Operating Expenses
- - - - - - - - - - - - - - -
Operating Income
136.67 123.30 118.96 36.34 82.58 171.05 161.27 155.07 151.49 118.77 126.72 103.12 75.87 61.86 58.50
Non-Operating Income
- - - - - - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - -
Interest Income
0.20 1.90 1.80 24.70 27.67 25.60 23.90 13.80 13.13 13.81 9.98 7.01 7.63 6.65 6.74
Interest Expense
57.37 59.90 58.16 44.92 50.81 52.88 56.30 49.06 46.32 43.11 37.63 26.37 9.23 2.07 -
Other Non-Op Income / Expense
3.70 0.40 0.60 0.60 -1.50 -3.13 - 0.00 0.00 -1.21 -1.77 -0.07 0.32 0.60 -
Income Before Tax
- - - - - - 161.27 155.07 151.49 118.77 126.72 103.12 75.87 - -
Income Tax Expense
- - - - - - 0.82 0.74 -7.87 -32.77 -22.14 1.51 -30.32 - -
Non-Controlling Interest
-1.39 -1.35 -1.27 -0.90 0.16 0.19 -0.01 0.00 0.00 1.18 1.45 1.44 1.00 - -
Net Income
142.18 137.99 135.65 66.40 111.80 185.13 160.46 154.33 159.37 151.54 148.86 101.61 106.18 81.13 0.00
Supplemental Per share data, derived & other items — not part of the income statement
in millions USD unless noted
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Dec 31, 2020 2020 FY Dec 31, 2019 2019 FY Dec 31, 2018 2018 FY Dec 31, 2017 2017 FY Dec 31, 2016 2016 FY Dec 31, 2015 2015 FY Dec 31, 2014 2014 FY Dec 31, 2013 2013 FY Dec 31, 2011 2011 FY Dec 31, 2010 2010 FY
Depreciation & Amortization
- - - - - - - - - - - - - - -
EBITDA
217.61 123.30 118.96 36.34 82.58 171.05 161.27 155.07 151.49 118.77 126.72 103.12 75.87 61.86 58.50
Earnings Per Share (Basic)
3.03 3.14 3.13 1.48 2.45 4.14 3.70 3.68 3.90 3.88 3.96 3.04 3.74 2.93 2.51
Diluted EPS
3.02 3.13 3.13 1.48 2.44 4.14 3.67 3.67 3.87 3.87 3.95 3.04 3.74 2.92 2.50
Weighted Average Shares
46.87 43.84 43.39 44.77 45.71 44.70 43.42 41.94 40.89 39.01 37.60 33.38 28.36 27.72 27.66
Diluted Weighted Avg Shares
47.05 44.10 43.39 44.79 45.73 44.70 43.70 42.09 41.15 39.16 37.64 33.42 28.40 27.79 27.73
Comprehensive Income
- - 135.65 66.40 118.95 181.41 155.73 156.22 152.81 129.36 170.55 98.29 108.17 72.98 70.65